SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems-Trading Strong Earnings Growth and Momentum -- Ignore unavailable to you. Want to Upgrade?


To: Sharck who wrote (3461)1/30/2001 9:45:47 PM
From: 2MAR$  Read Replies (1) | Respond to of 6445
 
Hey Charck , I was just going to post that to Jenna ,
she has to take time away from
those charts relax and tune into
the "Analysts get roasted! " in Prime Time ...

*High Priestess Mary Meeker should have turned on the
lights and checked which little god's were
creeping into her hammock at night that she
was lying in congress with , before she went out
and started crying out her exstacies.

"Recently, though, Morgan Stanley made millions in fees raising money for Priceline. Morgan's analyst, Mary Meeker, recommended buying Priceline's stock at $134 a share.

When it fell to $78, she repeated her buy recommendation. And she kept recommending Priceline as it fell to less than $3. "


Oops ...I mean "SHARK " !

;-)

*OPWV a bronco , huh?



To: Sharck who wrote (3461)1/31/2001 12:01:31 AM
From: Jenna  Read Replies (2) | Respond to of 6445
 
ATMI, LSBC and UTSI --- UTSI fundamentals/technicals merge, LSBC looking good here in the biotech sector. UTSI probably overbought, but this has places to go. ATMI lovely chart affordable, P/E of 16.7 with a peg of .17 and an EPS growth of 50%, earnings for ATMI February 7

marketgems.com
marketgems.com
marketgems.com